Thomas Silberg serves as Executive at Abraxis BioScience, Inc., where they oversee executive responsibilities. Since joining the company, Thomas Silberg has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Sep 10, 2008 involved selling 10,616 shares valued at $0.
Thomas Silberg currently holds 56,740 shares of Abraxis BioScience, Inc. (ABBI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas Silberg has been a net neutral trader of ABBI stock. They have purchased $0 and sold $0 worth of shares.
Thomas Silberg's most recent insider trade was on Sep 10, 2008, when they sold 10,616 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |